Collegium Pharmaceutical Announces 2025 Financial Guidance and Corporate Presentation – What Investors Need to Know
Collegium Pharmaceutical, Inc. (NASDAQ: COLL) recently disclosed its full-year revenue, adjusted operating expense, and adjusted EBITDA guidance for 2025 in a press release on January 8, 2025. The company also shared a corporate presentation on its website, offering insights into its strategic direction for the future. The press release attached to Collegium Pharmaceutical’s current report […]
More Stories
Southern Empire Resources (CVE:SMP) Trading 50% Higher – Time to Buy?
Shares of Southern Empire Resources Corp. (CVE:SMP – Get Free Report) rose 50% during trading on Tuesday . The company...
Richardson Electronics, Ltd. Declares Quarterly Dividend of $0.06 (NASDAQ:RELL)
Richardson Electronics, Ltd. (NASDAQ:RELL – Get Free Report) announced a quarterly dividend on Tuesday, January 7th,Wall Street Journal reports. Stockholders...
Putnam Premier Income Trust Plans Monthly Dividend of $0.03 (NYSE:PPT)
Putnam Premier Income Trust (NYSE:PPT – Get Free Report) announced a monthly dividend on Wednesday, January 8th,Wall Street Journal reports....
Premier Health of America (CVE:PHA) Stock Price Down 4.7% – Should You Sell?
Premier Health of America Inc. (CVE:PHA – Get Free Report)’s share price dropped 4.7% during trading on Tuesday . The...
AGNC Investment (NASDAQ:AGNCL) Stock Price Down 0.2% – Here’s What Happened
AGNC Investment Corp. (NASDAQ:AGNCL – Get Free Report)’s share price fell 0.2% on Tuesday . The stock traded as low...
Glass House Brands (OTCMKTS:GLASF) Shares Down 0.7% – What’s Next?
Glass House Brands Inc. (OTCMKTS:GLASF – Get Free Report) shares dropped 0.7% on Tuesday . The stock traded as low...